Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune tolerance split between hepatitis B virus precore and core proteins.

Margaret Chen1, Matti Sällberg, Janice Hughes

  • 1Vaccine Research Institute of San Diego, 3030 Bunker Hill St., Suite 300, San Diego, CA 92109, USA.

Journal of Virology
|February 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Molecular therapy. Advances·2026
Same author

Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2.

Molecular therapy. Nucleic acids·2026
Same author

Utility of the brief Patient Health Questionnaire-2 and Generalized Anxiety Disorder-2 screeners for depression and generalized anxiety symptom identification in people with human immunodeficiency virus.

HIV research & clinical practice·2026
Same author

APOL1 G1 and G2 risk alleles modulate severity of diet-induced obesity in a transgenic mouse model.

bioRxiv : the preprint server for biology·2026
Same author

Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Hepatitis B virus (HBV) precore antigen (HBeAg) promotes viral persistence by inducing T-cell tolerance. Different forms of tolerance, including deletion and anergy, were observed, with secreted HBeAg being more potent than intracellular HBcAg.

Area of Science:

  • Immunology
  • Virology
  • Hepatitis B Research

Background:

  • The function of hepatitis B virus (HBV) precore antigen (HBeAg) is unclear, though it may promote viral persistence and chronicity by regulating the immune system.
  • Understanding HBeAg's role is crucial for managing chronic HBV infections, particularly precore-negative cases.

Purpose of the Study:

  • To investigate the immunoregulatory role of HBV precore (HBeAg) and core (HBcAg) proteins in inducing T-cell tolerance.
  • To characterize the mechanisms and phenotypes of T-cell tolerance elicited by HBeAg and HBcAg.

Main Methods:

  • Generation of HBc/HBeAg-transgenic (Tg) mice crossed with T cell receptor (TCR)-Tg mice to create TCR-antigen double-Tg pairs.
  • Analysis of T-cell responses to HBc/HBeAgs to identify phenotypes of T-cell tolerance.

Related Experiment Videos

Main Results:

  • Identified three distinct phenotypes of HBe/HBcAg-specific T-cell tolerance: clonal deletion, clonal ignorance, and nondeletional tolerance (anergy).
  • Demonstrated that secreted HBeAg is more effective than intracellular HBcAg in inducing T-cell tolerance.
  • Observed split tolerance between HBeAg and HBcAg, indicating distinct tolerogenic properties.

Conclusions:

  • HBeAg plays a significant role in establishing T-cell tolerance, contributing to HBV persistence.
  • The differential tolerogenic capacity of HBeAg and HBcAg, along with clonal heterogeneity, has implications for HBV pathogenesis and treatment strategies.
  • Findings may inform approaches to managing chronic hepatitis B, especially precore-negative variants.